Description
GlycoFlux™ AAV1-ALG9 Viral Particle supplies ALG9 to advance lipid-linked oligosaccharide assembly, with mutations associated with CDG II and isoform-dependent specificity. AAV1 offers broad coverage across heart and liver with efficient gene delivery to CNS, retina, pancreas, inner ear, and smooth muscle, enabling organ-relevant glycosylation studies.
Product Type
Recombinant AAV1
Promotor
CMV, CAG, TRE, or other promoters
Tissue Tropism
Smooth muscle, Central Nervous System (CNS), Retina, Pancreas, Inner Ear, Heart, Liver
Packaging System
AAV Triple-Plasmid Transfection System
Application
This AAV1 viral particle is primarily used for overexpressing target genes in muscle tissues (smooth muscle, heart) and the central nervous system (CNS) / sensory organs (retina, inner ear). It is an ideal tool for research and pre-clinical studies focused on myopathies, cardiac disorders, and certain neurological or sensory genetic diseases.
Shipping
Shipped on dry ice, with temperature maintained at ≤ -80°C.
Storage
Store at -80°C to preserve viral titer and stability.
Handling Notes
Store this product at -80°C and minimize freeze-thaw cycles to preserve viral titer. For safety, handle in a certified biological safety cabinet and wear appropriate PPE (lab coat, gloves, and eye protection).
Product Disclaimer
This product is intended for research use only and is not approved for diagnostic procedures or clinical applications. Users are solely responsible for implementing appropriate safety practices and complying with all applicable laws, regulations, and institutional policies. While Creative Biolabs is committed to rigorous quality control, no guarantee is made regarding performance in any particular assay or application.